
HIV Pepfar funding cut, Motsoaledi confirms
Minister of Health Aaron Motsoaledi before his keynote address at Sandton Hotel in Johannesburg, 19 March 2025, on the need to prioritise TB during the 'End TB media workshop'. Picture: Nigel Sibanda/The Citizen
More than 8,000 healthcare workers in South Africa have lost their jobs following the withdrawal of United States (US) funding for HIV/Aids programmes, Health Minister Dr Aaron Motsoaledi confirmed on Thursday.
The job losses come as a direct result of US President Donald Trump's January 2025 announcement to withdraw the President's Emergency Plan for AIDS Relief (Pepfar) funding from South Africa's HIV/Aids and TB programmes.
During a media update, Motsoaledi addressed the impact of the funding cuts while countering claims that the country's HIV response has collapsed.
Despite the significant job losses, the health minister emphasised that the vast majority of the HIV/Aids workforce remains intact and operational across affected districts.
'In these 27 districts, there were 271 606 people who are working on the HIV/Aids programmes every day. 15 539 of these were funded by Pepfar , of which, yes, we can confirm today, unfortunately, 8 061 are out of their jobs,' Motsoaledi stated.
Despite these job losses, Motsoaledi emphasised that the remaining healthcare infrastructure continues to function.
'The remaining 7 478 people are still employed because they are funded through Centres for Disease Control and Prevention, or CDC, at least until September this year. So they are still on the job and doing their work as they were normally doing,' he explained.
ALSO READ: Jobs bloodbath as unemployment increases by 1% in first quarter
Motsoaledi counters claims of HIV programme collapse
Motsoaledi expressed concern about recent media narratives suggesting the HIV/Aids programme is collapsing following the funding withdrawal.
'Over the past three weeks, there have been numerous media statements, articles and claims by prominent South Africans who are well known within the HIV/Aids cycle.
'The general thrust of the narrative is that since the announcement on the 20th of January 2025 by President Donald Trump to withdraw funding from Pepfar — the HIV-Aids programme — has collapsed or is on the verge of collapsing, or is inevitably collapsing,' he noted.
The minister challenged what he characterised as a misguided perception about where HIV/Aids work truly takes place.
'It is rather unfortunate. There is a belief that the battle against HIV/Aids can only happen in offices or government buildings, public or private. And if the campaign is not seen there in such buildings, then it means it is not happening,' Motsoaledi remarked.
He emphasised that the real fight against the epidemic happens at the community level.
'We wish to confirm today that the fight against HIV/Aids and TB is in our villages, in our communities and townships and even on the streets of our country. And that is where our focus is, has been, and as it should be.'
ALSO READ: SA funds 90% of its HIV/Aids ARV programme, Motsoaledi reveals amid Pepfar uncertainty
Motsoaledi recalls South Africa's historic HIV crisis
During his address, the health minister reminded attendees of South Africa's history with HIV/Aids, particularly the devastating impact the epidemic had around 2010.
'Many here might have forgotten the real crisis brought about by HIV/Aids, which was the biggest crisis in the valley and happened in South Africa, especially around 2010, where death was an everyday occurrence,' Motsoaledi said.
'We were burying people in large numbers every day. There was a big absenteeism from work. Children were beaten as their mothers were dying.'
He highlighted the severity of the health crisis at its peak: 'By that time, maternal mortality driven by this pandemic had reached a staggering 249 per 100,000 live births. I want to repeat, a staggering 249 women were dying per every 100,000 live births. And the number of children who were born HIV positive was high.'
ALSO READ: Billions' worth of weight loss and diabetes medications reached SA shelves and patients in 2024
South Africa's HIV response strategy
Motsoaledi detailed how South Africa responded to the crisis by implementing an ambitious testing and treatment campaign.
'As a response, we launched the world's biggest HIV-cancelling testing and treatment campaign. We then announced that we're going to test 15 million South Africans in one year as part of that massive campaign,' he said.
The minister recalled that experts were sceptical about the feasibility of this goal.
'I want to remind you that we were never given a chance. Experts from all walks of life, including even the media, never gave us any chance because they thought we're just going to continue along the lines of voluntary counselling and testing, or VCT, as it was called at that time, which relied on passive self-reporting where people will come into health facilities to ask and ask to be tested.'
ALSO READ: Health experts warn of 'huge disaster' as USAID terminates Pepfar HIV funding in SA
HIV/Aids unattainable pipe dream' achieved
He noted that critics had dismissed the government's ambitious target.
'Our target of 15 million people was attacked as an unattainable pipe dream. And we were told that the best that we could achieve was to reach 3 million people only after one year of hard work.'
Despite these challenges, Motsoaledi explained how they pivoted their approach.
'We did not relent. We rather changed the approach from voluntary counselling and testing to what we then called HCD, HIV counselling and testing, meaning we go out in the villages, churches, places of work, communities, sport clubs, royal families, to offer South Africans cancelling and testing, and to put those who are positive on ARV treatment.'
The health minister highlighted the success of this approach: 'And contrary to the naysayers, I wish to remind you that we reached 18 million people in a period of 18 months in that programme.'
Despite the recent funding cuts from Pepfar, Motsoaledi emphasised that South Africa still maintains a substantial HIV/AIDS workforce, with 263,354 healthcare workers continuing to deliver critical services in previously Pepfar-funded districts.
He said those previously supported under Pepfar were absorbed into public clinics and continue to receive uninterrupted treatment.
NOW READ: Inside SA government's confused response to the USAid funding crisis
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Maverick
5 hours ago
- Daily Maverick
Dragon slayer — Dr Nomathemba Chandiwana battles obesity, ‘SA's new HIV epidemic'
The obesity epidemic will hit South Africa hard on top of our high HIV burden, but advocate researcher and scientist Dr Nomathemba Chandiwana says she is ready to fight back harder. She speaks to Spotlight about her journey from working in state hospitals to transitioning into obesity medicine, and her move to Cape Town. For the briefest moment, Dr Nomathemba Chandiwana could have had a career in music – guitar in her arms, singing songs of being far from home but being lost in the best way possible. The chief scientific officer at the Desmond Tutu Health Foundation has carved out a career in public health for more than a decade. Her focus has been on HIV and, most recently, bringing insights from HIV research into tackling South Africa's high rates of obesity. But in her late teens, her undergrad years were spent at Northeastern in Boston, United States, pursuing a Bachelor of Science in behavioural neuroscience. Her degree included a guitar credit, and she spent hours wandering through museums. 'It was some of the best experiences of my life, really – because I could be just another kid in just another college town. I got to learn that life isn't just for learning, it's also for learning about life,' she tells Spotlight. It was perspective she needed so that by the time she enrolled at Wits Medical School in 2006 for her third degree, it wasn't to tick boxes of expectation of a kid who got good grades; the daughter of a prominent virologist and the graduate accepted to study medicine in the United States. She would learn another lesson about expectation when frontline medicine didn't turn out to be her career path after all. She was well into her journey of becoming a paediatrician and had worked as a medical officer at three state hospitals in Johannesburg, when she says a series of devastating public service strikes, culminating in tragedy in 2012, 'broke' her. A health system failing people Nurses couldn't come to work and there were deaths, she recalls. 'I was young, barely out of medical school and I was in charge of kids in high care. In one week, 12 babies passed … and one of the nurses was killed,' says Chandiwana. She adds: 'It was the health system that failed people; it wasn't the doctors and nurses. It was so clear to me that we have to fix the healthcare system.' Her move from healthcare provider to researcher began with joining Wits RHI – a leading research institute that specialises in HIV, TB, sexual and reproductive health, vaccines and infectious diseases. Here she worked in strengthening health systems, focused on maternal, child and adolescent health. She says arriving at public health research has been her 'happy place'. Chandiwana helped to write the chapter on HIV treatment in the National Strategic Plan (NSP) for HIV, TB and STIs 2023-2028 and contributed to treatment guidelines on tuberculosis and sexually transmitted infections such as syphilis. Working at Wits' Ezintsha Research Centre with Professor Francois Venter, among the foremost HIV research scientists in South Africa, Chandiwana was part of a team that conducted a landmark study that confirmed the safety and efficacy of HIV treatment that includes the antiretroviral drug dolutegravir. More than four million people in South Africa have since started taking dolutegravir-based HIV treatment. Raising the profile of African research 'This was African-led research and data. So you're helping your own people with real answers that they need – it's not research for research's sake,' she says. 'Less than 2% of research output is from Africa, yet we are the continent with one of the highest disease burdens from Covid-19, to TB, HIV and malaria,' she says. African researchers, she says, have real challenges compared with their Global North colleagues. She points out, for instance, some medical journals have publishing fees that run into the thousands of dollars – fees that are hard to pay given the very tight budgets most local researchers have to work with. 'If you're an African researcher, it's not like you're doing just research. You're probably writing the protocol, you're looking for funding, you are training and teaching,' she says. But Chandiwana also says difficulties build resilience and adaptability – she calls it 'Africa's spunk'. She adds that publishing should not, in any case, supersede the goal of conducting research that has real impact. Chandiwana goes as far as saying that publishing in high-impact research journals is great, but publishing in medium-impact journals is important too. And that's not where it ends, she says, adding that social media messaging also has its role. A growing threat Around 2018, some of the groundbreaking research that Chandiwana was involved with at Ezintsha demanded just such a wider audience. She and her colleagues were seeing a peculiar but clear correlation between people with HIV taking certain ARVs and gaining weight. Researchers are still figuring out to what extent this weight gain is due to people simply putting on pounds because the ARVs are helping them get healthier, and to what extent some ARVs might contribute to weight gain in other ways. It was an important finding, potentially affecting many of the more than six million people on HIV treatment in South Africa (there is a total of around eight million people in SA living with the virus). The picture is further complicated by the fact that South Africa's population of people living with HIV is ageing, and therefore at greater risk of developing conditions such as obesity and diabetes simply because they are living longer. In March 2024, Chandiwana and Venter wrote an editorial in the South African Medical Journal, calling obesity 'South Africa's new HIV epidemic'. The editorial warned that the lessons and missteps of the HIV response in the late 1990s and early 2000s should be a wake-up call for the country's response to fighting obesity. 'As with the HIV epidemic in the 1990s, we are facing a calamitous threat to the health of the population that has been ignored for too long,' they wrote. 'Weight-related diseases have eclipsed tuberculosis and HIV as leading causes of morbidity and mortality. Over two-thirds of South African women are overweight or are living with obesity,' they warned, citing that type 2 diabetes, stroke and heart disease are conditions all directly linked to obesity. 'They account for three of the top four causes of death nationally and incur massive health system costs,' they wrote. Chandiwana and Venter also slammed the sluggish response from a government which has not even now reined in industries that prop up ultra-processed food systems through policies or regulations. 'This is how I transitioned into obesity medicine,' says Chandiwana, who since the end of 2024 has been based at the Desmond Tutu Health Foundation in Cape Town, led by Professor Linda-Gail Bekker. She counts Venter and Bekker as the mentors and value-based leaders she admires. 'Obesity is the disease of our time' Chandiwana says obesity research is still a relatively new field. There is no specific formal training on obesity in local medical schools. As such, her work is intertwined with advocacy, shaping policy direction and putting planning in place to push for equitable access to new drugs, treatments and therapies for obesity. (Spotlight previously published an in-depth feature on the case for using breakthrough new weight loss medicines in South Africa.) 'Obesity is the disease of our time, all throughout the world. Every country in the world has got an obesity issue, but low- and middle-income countries are most affected. So we have to ask questions about the environment in which people live, the role of fast foods and ultra processed foods, the built environment, the levels of safety and security in neighbourhoods and how this impacts things like how people feel about exercising outdoors, their quality of sleep, and their access to places where they can access nutritious foods,' she says. The other strand in tackling obesity, she points out, is in the rise of a new class of type 2 diabetes drugs called glucagon-like-peptide-1 receptor agonists (GLP-1 RAs), increasingly also used to treat obesity. For instance, the diabetes medication Semaglutide can work to reduce appetite, help people feel fuller for longer and slow down gastric emptying, thereby promoting weight loss. (Spotlight previously published an article on which of the breakthrough weight loss medicines are available in South Africa and at what price.) These drugs are gamechangers, Chandiwana says. With treatment available, it means obesity can be seen and treated as a chronic metabolic disease. It helps to shed the stigma that obesity is simply an affliction caused by poor willpower and bad lifestyle choices. But the catch is the high price of the drugs, making questions about fair access to treatment top of mind for Chandiwana. As an HIV physician and research advocate, there are many parallels Chandiwana draws about these new drugs and ARVs in the early days of getting treatment to people living with HIV. Ultimately, it's about who gets left behind. And once again, even in the case of obesity in South Africa, she says it's black women most at risk. 'My research interest is therefore also about how to make sure we have comprehensive treatment plans that include looking at environment, food and lifestyle. Everyone should be allowed to increase not just their lifespan but their health-span, including through access to antiretrovirals, anti-obesity drugs, diabetic drugs or hypertension drugs,' she says. Putting people at the heart of research Chandiwana says her research approach is shaped by community strategies, building advocacy and training others, and locally appropriate solutions and interventions. One project Chandiwana highlights is the work the Desmond Tutu Health Foundation does at the Mpilo Health Park in Masiphumelele, Cape Town. It is where youth can access sexual and reproductive health services and also use an on-site gym and sports grounds. The idea is that combining services means looking to more holistic interventions to improve health, wellbeing and even access to secure recreational spaces for young people. 'There is no research without communities. They are the people who say 'yes' to being part of research – yes, they'll help us find answers. It is not researchers doing it by themselves,' she says. Chandiwana is intentional about putting people at the heart of research. She says people know what works best for them ultimately and people, when they're heard, can sway governments. 'As a researcher, I believe I am a storyteller. Research is not something abstract or just about the data, for me it's people's stories that I am telling,' says Chandiwana. Falling in love with Cape Town Her own story has seen her become a Capetonian. It was unexpected, she says, and so was becoming a Capetonian with a dog who enjoys going on long hikes, she jokes. But the die-hard ex-Joburger admits to falling in love with Cape Town more deeply each day. It's home now for her, husband Zviko Mudimu, their two children and nanny Thembi Ndlovu. 'I was one of those people who said I could never live in Cape Town,' Chandiwana says of the city's notoriously blatant racial and wealth divides. 'One of the things I remind myself of in Cape Town is that I might be pushing in spaces that I've been told are not meant for me. I have to remind myself that it's my country too, and I am allowed. Some things about Cape Town do need a shake-up,' she says. She calls for dragon slayers in a time of dragons – drawing an analogy from her soft spot for high fantasy and science fiction. But she also admits that Cape Town has made her check her assumptions and expectations. It's surprised and shaken her, too. Reciprocal action, after all, can be how change is made. And change in the right direction is what keeps her going, or as she puts it on her WhatsApp status, to 'chop wood, carry water'. Chandiwana adds: 'The whole point of the work we do is that we believe we're leaving our corner of the world a little better off. Sometimes it's about pushing back, becoming a bigger advocate, and working with imperfect allies. In the end, it's about finding more ways to walk this road we're on.' DM


The Citizen
2 days ago
- The Citizen
Labour department can't pursue medical aid ‘discrimination', Motsoaledi to seek reforms
Health minister Aaron Motsoaledi stated he would seek changes to Medical Schemes Act that regulates 'intrusive' administrators The Department of Employment and Labour (DEL) has its hands tied when it comes the medical aid scheme 'racism' report, while the health department is pressing on with plans to reform the sector. Both departments provided updates on their positions earlier in August via written responses to parliamentary questions on the matter. In July, a Section 59 investigation report accused certain medical aid schemes of racial bias in their handling of fraud, waste and abuse (FWA) investigations against healthcare providers. The report was compiled by Advocate Tembeka Ngcukaitobi and the findings were based off an algorithm that the accused parties consider to be vague and flawed. 'No legal basis' for labour department The parliamentary question sent to the DEL asked what immediate corrective measures would be taken, how the situation would be monitored, and if there would be any investigation into the medical aid schemes. Minister Nomakhosazana Meth explained that there was no legislation that permitted DEL's involvement and that any dispute was between commercial entities. 'Even the Employment Equity Act (EEA) provides no legal mandate that could place it as a respondent to the specified report. 'There will be no immediate corrective measures that the department will be undertaking to address the specified practices in the public health working environment,' stated Meth. The question posed of the DEL called for the implementation of anti-discrimination policies and asked if the minister supported legal action against medical aid schemes. Meth stressed the EEA existed to promote equal opportunity and fair treatment in the workplace, but no measures relating to the report would be considered. 'There will be no investigation conducted by the department into the discriminatory practices of the medical schemes because it falls outside the ambit and regulatory framework of the EEA. 'The department has no legal powers to collaborate with other relevant stakeholders to develop and implement anti-discrimination policies,' Meth concluded. Medical aids fighting waste Medical aid schemes vehemently defended themselves, stressing that the report made no legal findings and that the data was 'unreliable'. 'This inaccurate narrative undermines the integrity of medical schemes and their duty to protect members' funds from being paid out inappropriately,' stated the Health Funder Association (HFA). 'The statistical findings in the final report were derived from analyses conducted by a single expert who classified health providers by race using their surnames. This methodology has been widely criticised as unreliable and flawed,' the HFA explained. The Board of Healthcare Funders (BHF) was equally dismissive of the report, highlighting the cost of FWA. 'Fraudulent claims, over-servicing, abuse of benefits, and improper billing practices cost South Africa's medical schemes around R30 billion each year,' stated BHF Managing Director Katlego Mothudi. 'We will not be deterred by unfounded claims of racial bias – corruption is corruption and must be rooted out,' he added. Motsoaledi's plans Health Minister Aaron Motsoaledi's response stated that the department was working with the Council for Medical Schemes to appoint a firm to form a legal opinion on their behalf. He explained that this opinion would determine the department's course of action, but confirmed he supported legislative reforms; even using the Financial Sector Conduct Authority and the Prudential Authority to 'strengthen deterrence' against discrimination. 'I do support legislative and/or regulatory amendments to provide stronger oversight and enforcement powers over medical schemes engaging in discriminatory conduct,' stated the minister. The report suggested the establishment of a tribunal and greater transparency over schemes' adjudication software, which Motsoaledi said would be overseen by an internal task team. The minister said he would seek 'urgent amendments' to Section 59(3) of the Medical Schemes Act which outlines how medical aids are able to claim funds back from healthcare providers. '[This section] is light on regulatory detail and could be expanded upon so that it properly regulates the more intrusive aspects of the FWA systems developed by schemes and their administrators over the last decade,' stated Motsoaledi. NOW READ: Medical aids slammed for procedural unfairness in new report


The Citizen
2 days ago
- The Citizen
Rooibos and broccoli protect the heart
Biochemist Sinenhlanhla Mthembu reveals how rooibos and broccoli can help combat heart disease, a leading cause of death in South Africa. Broccoli and rooibos, common food items in South Africa, have been found to help protect against the leading cause of death: heart disease. This significant finding has emerged from research conducted by a young biochemist at North-West University's (NWU) Mahikeng campus, Sinenhlanhla Mthembu. She embarked on a mission to explore the potential role of plant-based compounds in combating heart damage associated with metabolic disorders. After dedicated research for her PhD degree, for which she graduated in July, Mthembu successfully demonstrated that both broccoli and rooibos possess the ability to protect the heart. Broccoli and rooibos can protect heart KwaZulu-Natal-born Mthembu, 27, had set herself on a research journey with a special focus. She had people in mind and how this lifestyle disease had now begun to devastate rural communities due to changing lifestyles. 'I was motivated by a desire to tackle real health challenges that affect people's lives,' Mthembu says. ALSO READ: [REVIEW] Huawei's Watch Fit 4 Pro an Apple watch killer? 'Heart disease and lipid-related disorders are major concerns, especially in South Africa, and I wanted to explore how everyday foods like rooibos and broccoli, foods many of us enjoy daily, can protect the heart.' Mthembu's study addressed the question why cardiovascular complications continue to rise, despite the availability of conventional therapies. The findings point to affordable, plant-based interventions as a potential solution. Affordable, plant-based interventions While the body naturally produces disease-fighting antioxidants such as coenzyme Q10, which is critical for heart health, metabolic complications such as dyslipidemia can disrupt these molecules, she says. 'Natural compounds such as aspalathin from rooibos and sulforaphane from broccoli can restore antioxidants, improve energy metabolism and shield heart cells from oxidative damage. 'This could improve outcomes for patients facing cardiovascular complications.' ALSO READ: Lifesaving heart surgery gives baby Oaheng a second chance to shine Mthembu is grateful to the South African Medical Research Council that supported her during her studies. But she reserved special thanks to her mentor and supervisor, Prof Sithandiwe Mazibuko-Mbeje from the biochemistry department 'who supported not only my lab work but also my dreams'. NWU vice-chancellor and principal Prof Bismark Tyobeka spoke about the young scientist's research work and how it would put NWU on the world map. Noting Mthembu's excellent research outcomes and alluding to her humble rural background, Tyobeka said, 'one's origins do not dictate one's potential and destination'. Cardiovascular disease top 3 causes of death in SA According to Discovery, cardiovascular disease is one of the top three causes of death in South Africa, ahead of HIV/Aids and TB combined in terms of mortality. The South African Heart Association said the disease was among the top three causes of death in sub-Saharan Africa. Discovery said approximately 78 475 people die from heart disease annually, or about 215 deaths per day in South Africa. NOW READ: The silent threat of hyperlipidaemia lurking in everyday joys